Epigenetics · 2010 · 28 citations · 23 references
Life SciencesGeneticsMolecular BiologyEpigeneticsGene ExpressionGenomicsDiabetes MellitusDiabetic Kidney DiseaseDiabetic NephropathyDna MethylationDna Methylation ProfilingRenal DiseaseCell-type Specific MethylationCpg Methylation SignaturesDisease-specific Methylation SignaturesDna Methylation PatternsMethylome ProfilingPromoter Methylation AnalysisSite-specific Dna Methylation Markers
We have previously identified differentially expressed genes in cell models of diabetic nephropathy and renal biopsies. Here we have performed quantitative DNA methylation profiling in cell models of diabetic nephropathy. Over 3,000 CpG units in the promoter regions of 192 candidate genes were assessed in unstimulated human mesangial cells (HMCs) and proximal tubular epithelial cells (PTCs) compared to HMCs or PTCs exposed to appropriate stimuli. A total of 301 CpG units across 38 genes (~20%) were identified as differentially methylated in unstimulated HMCs versus PTCs. Analysis of amplicon methylation values in unstimulated versus stimulated cell models failed to demonstrate a >20% difference between amplicons. In conclusion, our results demonstrate that (1) specific DNA methylation signatures are present in HMCs and PTCs, and (2) standard protocols for exposure of renal cells to stimuli that alter gene expression may be insufficient to replicate possible alterations in DNA methylation profiles in diabetic nephropathy.
23
The changing natural history of nephropathy in type I Diabetes
Andrzej S. Królewski, James H. Warram, A.Richard Christlieb et al. · The American Journal of Medicine · 1985 · 782 citations
Medicine, Endocrinology, Nephrology +12
Mitsuo Kato, Jane Zhang, Mei Wang et al. · Proceedings of the National Academy of Sciences · 2007 · 699 citations · Full text
TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN
Mitsuo Kato, Sumanth Putta, Mei Wang et al. · Nature Cell Biology · 2009 · 583 citations · Full text